Hypoxia-Inducible Factor-1α and Interleukin 33 Form a Regulatory Circuit to Perpetuate the Inflammation in Rheumatoid Arthritis

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Hu, Fanlei ^a   Shi, Lianjie ^a   Mu, Rong ^a   Zhu, Jiaxin ^a   Li, Yingni ^a   Ma, Xiaoxu ^a   Li, Chun ^a   Jia, Rulin ^a   Yang, Dongyue ^a   Li, Yun ^a   Li, Zhanguo ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 33; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; IL33 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; ENZYME ACTIVATION; FIBROBLAST; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; INFLAMMATION; OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIAL FLUID LEVEL; UPREGULATION; BIOLOGICAL MODEL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; SYNOVIAL FLUID;

ARTHRITIS, RHEUMATOID; FIBROBLASTS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; INTERLEUKINS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; SYNOVIAL FLUID;

EID: 84881574228     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072650     Document Type: Article

References (29)

1. Sokka T, (2003) Work disability in early rheumatoid arthritis. Clin Exp Rheumatol 21: S71-74.
2. Ulfgren AK, Lindblad S, Klareskog L, Andersson J, Andersson U, (1995) Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis 54: 654-661.
3. van Oosterhout M, Levarht EW, Sont JK, Huizinga TW, Toes RE, et al. (2005) Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12. Ann Rheum Dis 64: 537-543.
4. Samson M, Audia S, Janikashvili N, Ciudad M, Trad M, et al. (2012) Inhibition of IL-6 function corrects Th17/Treg imbalance in rheumatoid arthritis patients. Arthritis Rheum.
5. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, et al. (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490.
6. Chackerian AA, Oldham ER, Murphy EE, Schmitz J, Pflanz S, et al. (2007) IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol 179: 2551-2555.
7. Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, et al. (2007) IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A 104: 282-287.
8. Luthi AU, Cullen SP, McNeela EA, Duriez PJ, Afonina IS, et al. (2009) Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 31: 84-98.
9. Xu D, Jiang HR, Kewin P, Li Y, Mu R, et al. (2008) IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci U S A 105: 10913-10918.
10. Palmer G, Talabot-Ayer D, Lamacchia C, Toy D, Seemayer CA, et al. (2009) Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum 60: 738-749.
11. Mu R, Huang HQ, Li YH, Li C, Ye H, et al. (2010) Elevated serum interleukin 33 is associated with autoantibody production in patients with rheumatoid arthritis. J Rheumatol 37: 2006-2013.
12. Lund-Olesen K, (1970) Oxygen tension in synovial fluids. Arthritis Rheum 13: 769-776.
13. Naughton DP, Haywood R, Blake DR, Edmonds S, Hawkes GE, et al. (1993) A comparative evaluation of the metabolic profiles of normal and inflammatory knee-joint synovial fluids by high resolution proton NMR spectroscopy. FEBS Lett 332: 221-225.
14. Peters CL, Morris CJ, Mapp PI, Blake DR, Lewis CE, et al. (2004) The transcription factors hypoxia-inducible factor 1alpha and Ets-1 colocalize in the hypoxic synovium of inflamed joints in adjuvant-induced arthritis. Arthritis Rheum 50: 291-296.
15. Ng CT, Biniecka M, Kennedy A, McCormick J, Fitzgerald O, et al. (2010) Synovial tissue hypoxia and inflammation in vivo. Ann Rheum Dis 69: 1389-1395.
16. Hollander AP, Corke KP, Freemont AJ, Lewis CE, (2001) Expression of hypoxia-inducible factor 1alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum 44: 1540-1544.
17. Thornton RD, Lane P, Borghaei RC, Pease EA, Caro J, et al. (2000) Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts. Biochem J 350 Pt 1: 307-312.
18. Westra J, Brouwer E, Bos R, Posthumus MD, Doornbos-van der Meer B, et al. (2007) Regulation of cytokine-induced HIF-1alpha expression in rheumatoid synovial fibroblasts. Ann N Y Acad Sci 1108: 340-348.
19. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, et al. (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10: 858-864.
20. Biniecka M, Fox E, Gao W, Ng CT, Veale DJ, et al. (2011) Hypoxia induces mitochondrial mutagenesis and dysfunction in inflammatory arthritis. Arthritis Rheum 63: 2172-2182.
21. Hot A, Zrioual S, Lenief V, Miossec P, (2012) IL-17 and tumour necrosis factor alpha combination induces a HIF-1alpha-dependent invasive phenotype in synoviocytes. Ann Rheum Dis 71: 1393-1401.
22. Hu F, Mu R, Zhu J, Shi L, Li Y, et al. (2013) Hypoxia and hypoxia-inducible factor-1alpha provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis. Ann Rheum Dis doi:10.1136/annrheumdis-2012-202444.
23. Ahn JK, Koh EM, Cha HS, Lee YS, Kim J, et al. (2008) Role of hypoxia-inducible factor-1alpha in hypoxia-induced expressions of IL-8, MMP-1 and MMP-3 in rheumatoid fibroblast-like synoviocytes. Rheumatology (Oxford) 47: 834-839.
24. Kunisch E, Chakilam S, Gandesiri M, Kinne RW, (2012) IL-33 regulates TNF-alpha dependent effects in synovial fibroblasts. Int J Mol Med 29: 530-540.
25. Millar NL, Reilly JH, Kerr SC, Campbell AL, Little KJ, et al. (2012) Hypoxia: a critical regulator of early human tendinopathy. Ann Rheum Dis 71: 302-310.
26. Haraldsen G, Balogh J, Pollheimer J, Sponheim J, Kuchler AM, (2009) Interleukin-33- cytokine of dual function or novel alarmin? Trends Immunol 30: 227-233.
27. Roussel L, Erard M, Cayrol C, Girard JP, (2008) Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket. EMBO Rep 9: 1006-1012.
28. Mun SH, Ko NY, Kim HS, Kim JW, Kim do K, et al. (2010) Interleukin-33 stimulates formation of functional osteoclasts from human CD14(+) monocytes. Cell Mol Life Sci 67: 3883-3892.
29. Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, et al. (2011) Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 146: 772-784.